ATS Corp /ATS
No SEC Form 4 filings for $ATS in the last 30 days.
See all $ATS insider activity →ATS Corporation reported Q1 fiscal 2027 results on Aug. 6, 2026. Adjusted revenue was $698 million, down 5% y/y, and adjusted EPS was $0.35. Adjusted earnings from operations fell 13.4% to $68.1 million. Order backlog was $1.9 billion and Q2 revenue guidance was $660 million to $700 million. ATS also outlined an 18-month transformation program and $70m to $90m capex guidance.
ATS Corporation said all nominees in its June 22, 2026 management information circular were elected directors at its Aug. 6, 2026 annual meeting. Voting turnout was 88.12%. ATS also reported NCIB purchases of 146,085 shares at an average $29.08, totaling about $4.25 million, with capacity up to 8,225,621 shares.
ATS said it will consolidate some European facilities and shift technical capabilities to sites with capacity. Management expects the first phase to deliver about CAD 20 million in annualized savings, about 30% of the total fixed-cost program (CAD 60-70 million). Q1 restructuring costs were CAD 5.7 million and non-cash charges CAD 21.5 million. ATS guided Q2 revenue to CAD 660-700 million.
Over the past 7 days, alphai's AI scored 2 news stories mentioning ATS (ATS Corp /ATS). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent ATS coverage spans earnings, corporate actions and financial news.
Near-term trading focus is on Q2 revenue conversion of backlog plus margin trajectory from the transformation and service mix.
Board election is routine, but the disclosed NCIB buyback adds a near-term capital allocation signal and potential support for the stock.
Restructuring and margin roadmap (fixed-cost savings plus higher-margin services) are the core near-term drivers for ATS’s earnings power and cost trajectory.
The new fixed-cost program and the reported Q1 deterioration (revenue down, net loss vs profit) create a near-term earnings and margin narrative, with execution risk on Europe footprint consolidation.
Option exercise followed by sale is typically liquidity/compensation-related; signal strength is low absent additional context.
alphai scores every news story that mentions ATS with an AI model for sentiment and relevance, and aggregates insider trades from ATS Corp /ATS's SEC EDGAR Form 4 filings. Figures refresh continuously.
ATS Corporation reported Q1 fiscal 2027 results on Aug. 6, 2026. Adjusted revenue was $698 million, down 5% y/y, and adjusted EPS was $0.35. Adjusted earnings from operations fell 13.4% to $68.1 million. Order backlog was $1.9 billion and Q2 revenue guidance was $660 million to $700 million. ATS also outlined an 18-month transformation program and $70m to $90m capex guidance.
6 min readATS Corporation said all nominees in its June 22, 2026 management information circular were elected directors at its Aug. 6, 2026 annual meeting. Voting turnout was 88.12%. ATS also reported NCIB purchases of 146,085 shares at an average $29.08, totaling about $4.25 million, with capacity up to 8,225,621 shares.
2 min readATS said it will consolidate some European facilities and shift technical capabilities to sites with capacity. Management expects the first phase to deliver about CAD 20 million in annualized savings, about 30% of the total fixed-cost program (CAD 60-70 million). Q1 restructuring costs were CAD 5.7 million and non-cash charges CAD 21.5 million. ATS guided Q2 revenue to CAD 660-700 million.
6 min readATS Corporation reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Revenues were C$693.7 million versus C$736.7 million a year earlier, with a C$0.3 million net loss. Adjusted EBITDA was C$92.9 million. ATS also announced an 18-month Fixed Cost Transformation Program, targeting 15% adjusted earnings from operations margin, with an initial European footprint consolidation and expected C$20 million annual cost reductions.
6 min readThe article lists recent insider selling/option exercises in four stocks. Aritzia’s lead independent director John Currie sold 5,000 shares for about $776,000 (May 28). ATS Corp’s Joe Tassone exercised and sold 4,842 shares for over $100,000 (June 2). Avino’s Carlos Rodriguez sold 56,700 shares for over $570,000 (May 29). BMO’s Sharon Haward-Laird exercised and sold 8,320 shares for over $1.1 million (June 1).
4 min readATS reported Q4 2026 adjusted revenues of $744 million (+3.2%); organic growth was 1.5% with a 1.7% FX benefit. Q4 adjusted earnings from operations rose 3.4% to $76.8 million; gross margin was 29.4%. Order bookings were $704 million (-18.4%) and backlog about $2 billion. Fiscal 2027 guidance calls for Q1 revenues $700–$740 million and modest full-year growth, with margin improving 50–75 bps.
6 min readOn May 29, analysts adjusted price targets across multiple stocks. Aclarion (ACON) was raised to $7.50 (Ascendiant). Autodesk (ADSK) saw mixed cuts and hikes, including Piper Sandler to $369 and Citigroup to $252. American Eagle (AEO) targets fell to as low as $17 (Barclays) and $19 (JPMorgan). Amazon (AMZN) rose to $320 (Truist).
2 min readATS Corporation reported a narrower Q4 2026 net loss for the quarter ended March 31, 2026, citing higher revenues partly offset by higher SG&A. Net loss fell to C$16.2m (from C$68.9m); loss per share to C$0.16 (from C$0.70). Total revenue rose to C$747.1m (from C$574.2m). Outlook for Q1 2027: revenue C$700m–C$740m. Shares closed at $35.27.
4 min readATS (NYSE:ATS) reported fiscal 2026 revenue and adjusted earnings from operations each up about 11%, with Q4 adjusted revenue at CAD 744 million (+3.2%) and adjusted earnings from operations at CAD 76.8 million (+3.4%). Management outlined restructuring to improve margins and cash, including repositioning transportation, expected to remove ~CAD 50 million of dilutive revenue. Q4 order bookings fell 18.4% to CAD 704 million.
7 min readATS (NYSE:ATS) reported quarterly EPS of $0.26, missing the $0.32 consensus estimate by $0.06, according to Zacks. The article also cites ROE of 9.67% and net margin of 0.77%. Shares opened at $35.41; the stock has a $3.47B market cap and a $35.00 average analyst target, with consensus rated “Hold” by MarketBeat.
4 min read
